Fournier M, Mal H, Andreassian B, Pariente R
Service de Pneumologie et Réanimation, Hôpital Beaujon, Clichy, France.
Lung. 1990;168 Suppl:1169-71. doi: 10.1007/BF02718258.
We report six single-lung transplantations in emphysematous patients with end-stage disease. Compression of the graft or ventilation/perfusion imbalance were not observed. Rejection episodes were generally documented through transbronchial biopsies and the radiological changes related to acute infections or rejections were restricted to the transplanted lung. Three patients died from CMV pneumonia, status epilepticus and fibrosis of the graft following bronchography, respectively. The three remaining patients are well, with documented improvement of pulmonary function tests and arterial blood gases. Bronchial complications were observed in all patients and have in some cases required dilatation or insertion of a stent. Although requiring a longer follow up, single transplantation is feasible and beneficial in patients with end-stage emphysema.
我们报告了6例为终末期肺气肿患者进行的单肺移植手术。未观察到移植肺受压或通气/灌注失衡情况。排斥反应通常通过经支气管活检记录,与急性感染或排斥反应相关的放射学变化仅限于移植肺。3例患者分别死于巨细胞病毒性肺炎、癫痫持续状态和支气管造影术后移植肺纤维化。其余3例患者情况良好,肺功能测试和动脉血气分析显示有改善记录。所有患者均观察到支气管并发症,部分病例需要进行扩张或置入支架。尽管需要更长时间的随访,但单肺移植对于终末期肺气肿患者是可行且有益的。